Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

NSS Labs Adds Dina Bruzek as Senior Vice President of Products


Posted on: 29 Nov 17

AUSTIN, Texas, Nov. 29, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that Dina Bruzek has joined the company as Senior Vice President of Products. In this role, Dina will execute the product strategy across the company’s engineering and product management groups delivering on the CAWS Continuous Security Validation Platform.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a12d83a3-9edc-4167-be82-237dcab8119c

“Dina brings a wealth of experience driving the development of market-leading cybersecurity products,” said Vikram Phatak, CEO of NSS Labs. “Her expertise as a global product leader for enterprise-class security products will help to accelerate the delivery of NSS Labs’ Continuous Security Validation platform, enabling enterprises to gain peace of mind and know that their security controls are working.” 

Dina has more than 20 years of experience in technical, product development, and strategic leadership roles in the cybersecurity industry. Most recently, she led Cisco’s Network Threat Defense (NTD) group, where she oversaw a $1.5 billion product portfolio and led the company’s strategy to deliver the first threat-centric next generation firewall. She assumed this role following Cisco’s 2013 acquisition of Sourcefire for $2.7 billion. Prior to the acquisition, Dina was the Vice President of Product Development at Sourcefire, where she was responsible for software and hardware development for Sourcefire’s network security products.

“NSS Labs has a unique opportunity to build on its strong foundation of security product testing and CAWS Continuous Security Validation Platform,” said Dina Bruzek, Senior Vice President of Products at NSS Labs. “I look forward to working with the NSS Labs team and our enterprise customers as we continue to evolve our products and services to address changing market requirements and challenging security problems.” 

Additional Resources: 

About NSS Labs, Inc.
NSS Labs, Inc. is recognized globally as the most trusted source for independent, fact-based cybersecurity guidance. Our mission is to advance transparency and accountability within the cybersecurity industry. We empower enterprises by providing them with timely, relevant information on which to base their decisions. Our unmatched foundation in security testing, along with our extensive research and global threat analysis capabilities, provide the basis for our CAWS Continuous Security Validation Platform. CAWS measures the ongoing effectiveness of security controls, providing a real-time score card to help business leaders substantiate their security investments. Businesses can also leverage the threat data delivered by CAWS to strengthen their cyber risk posture and mitigate threats to their operating systems and applications. CISOs, Chief Security Architects, SOC and Threat Analysts, and information security professionals from many of the world's largest and most demanding enterprises rely on trusted insights from NSS Labs. For more information, visit www.nsslabs.com.

Contact:
Tom Resau
W2 Communications
Phone: +1 703-877-8103
tom@w2comm.com

GlobeNewswire
globenewswire.com

Last updated on: 30/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.